BRIEF-AstraZeneca lung cancer drug delays disease by more than a year
April 17, 2015 at 03:09 AM EDT
* Astrazeneca announces updated progression free survival data for investigational non-small cell lung cancer medicine AZD9291
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.